Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9045-50. doi: 10.1073/pnas.0900452106. Epub 2009 May 18.

Abstract

Identification of the binary interactions between viral and host proteins has become a valuable tool for investigating viral tropism and pathogenesis. Here, we present the first systematic protein interaction screening of the unique variola virus proteome by using yeast 2-hybrid screening against a variety of human cDNA libraries. Several protein-protein interactions were identified, including an interaction between variola G1R, an ankryin/F-box containing protein, and human nuclear factor kappa-B1 (NF-kappaB1)/p105. This represents the first direct interaction between a pathogen-encoded protein and NF-kappaB1/p105. Orthologs of G1R are present in a variety of pathogenic orthopoxviruses, but not in vaccinia virus, and expression of any one of these viral proteins blocks NF-kappaB signaling in human cells. Thus, proteomic screening of variola virus has the potential to uncover modulators of the human innate antiviral responses.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Line
  • Gene Library
  • Host-Pathogen Interactions*
  • Humans
  • NF-kappa B p50 Subunit / antagonists & inhibitors*
  • NF-kappa B p50 Subunit / metabolism
  • Orthopoxvirus / metabolism
  • Orthopoxvirus / pathogenicity
  • Proteomics*
  • Two-Hybrid System Techniques
  • Variola virus / metabolism*
  • Viral Proteins / metabolism*

Substances

  • NF-kappa B p50 Subunit
  • NFKB1 protein, human
  • Viral Proteins